Corvus Pharmaceuticals, Inc. (CRVS): Shares Outstanding
74.70M
As of 2025-12-31
84.12M
As of 2026-06-30
+17.1%
3-year compound annual growth
+21.4%
5-year compound annual growth
n/m
10-year compound annual growth
| Period ended | Shares Outstanding | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 74.70M | +10.0% | 2026-03-12, Balance as of period end |
| 2024-12-31 | 67.90M | +38.5% | 2026-03-12, Balance as of period end |
| 2023-12-31 | 49.04M | +5.3% | 2025-03-25, Balance as of period end |
| 2022-12-31 | 46.55M | 0.0% | 2024-03-19, Balance as of period end |
| 2021-12-31 | 46.55M | +64.1% | 2022-03-10, Balance as of period end |
| 2020-12-31 | 28.37M | +1.5% | 2022-03-10, Balance as of period end |
| 2019-12-31 | 27.95M | -4.7% | 2021-03-25, Balance as of period end |
| 2018-12-31 | 29.32M | +39.4% | 2020-03-09, Balance as of period end |
| 2017-12-31 | 21.04M | +0.6% | 2019-03-07, Balance as of period end |
| 2016-12-31 | 20.92M | n/m | 2018-03-01, Balance as of period end |
| 2015-12-31 | 1.43M | n/a | 2017-03-10, Balance as of period end |